Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142804 |
| CAS No | NA |
| Mol.F. | C17H16Cl2N2O4 |
| Mol.Wt. | 383.23 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142805 |
| CAS No | NA |
| Mol.F. | C18H18N2O2 |
| Mol.Wt. | 294.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142806 |
| CAS No | NA |
| Mol.F. | C18H18N2O2 |
| Mol.Wt. | 294.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142807 |
| CAS No | NA |
| Mol.F. | C18H20N2O3 |
| Mol.Wt. | 312.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142808 |
| CAS No | NA |
| Mol.F. | C18H18N2O2 |
| Mol.Wt. | 294.35 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142809 |
| CAS No | NA |
| Mol.F. | C9H12N2O2 |
| Mol.Wt. | 180.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142810 |
| CAS No | NA |
| Mol.F. | C15H20N2O3 |
| Mol.Wt. | 276.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142811 |
| CAS No | NA |
| Mol.F. | C15H20N2O2 |
| Mol.Wt. | 260.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142812 |
| CAS No | NA |
| Mol.F. | C15H22N2O2 |
| Mol.Wt. | 262.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142813 |
| CAS No | NA |
| Mol.F. | C15H10ClN3O2 |
| Mol.Wt. | 299.71 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142814 |
| CAS No | NA |
| Mol.F. | C16H12ClN3O2 |
| Mol.Wt. | 313.74 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142815 |
| CAS No | NA |
| Mol.F. | C25H22ClN3O3 |
| Mol.Wt. | 447.92 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142816 |
| CAS No | NA |
| Mol.F. | C14H12ClN3O |
| Mol.Wt. | 273.72 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142817 |
| CAS No | NA |
| Mol.F. | C10H12N2O3S2 |
| Mol.Wt. | 272.34 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142818 |
| CAS No | NA |
| Mol.F. | C10H15N3O5S3 |
| Mol.Wt. | 353.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142819 |
| CAS No | NA |
| Mol.F. | C10H13N3O6S3 |
| Mol.Wt. | 367.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |